Market July 16: AI Stocks Dumped, Healthcare Ripped, and the Index Shrugged

TL;DR

• The AI complex got marked down again: SMH -3.2%, Arm -8%, Micron -8% on China fears, AMD -5%, SK Hynix's ADR -8%.
• The money didn't leave the market. It walked across the street: Abbott +11% and UnitedHealth +3% on earnings beats, healthcare led every sector, and the Dow outperformed.
• Index scoreboard: S&P -0.3%, Nasdaq -1%, on a day when 87% of reporting S&P companies have beaten estimates. Earnings are fine. Positioning is the problem.
• Tomorrow decides plenty: TSMC and Netflix report Thursday, and TSMC is now a referendum on the entire wounded AI trade.

The Board

One session, two markets: healthcare with earnings receipts on the left, the AI trade getting repriced on the right.

What Actually Happened

Three separate hammers hit the AI trade in one session, and none of them was a war headline.

China showed up with an invoice. CXMT, China's state-backed DRAM maker, announced an $8.5 billion IPO, the country's biggest of 2026, to scale domestic memory production. It's already the world's fourth-largest DRAM producer and grew revenue sevenfold in the first half. That's a direct shot at the supply-shortage thesis holding up the entire memory trade, and Micron paid for it instantly, full breakdown in the MU piece.

Jensen did math in public. Huang's remark that AI computing costs are heading from ~$50 billion toward $100 billion per gigawatt got picked up by Seaport as a structural problem: at those costs, Nvidia increasingly has to help finance its own customers. The street heard "vendor financing" and remembered how that movie ended last time, covered in the gigawatt piece.

Broadcom guided AI revenue up 200% and got sold. When tripling your AI business is a sell event, the multiple has outrun every number the company can print. That's the sell-the-news autopsy, and it's the purest positioning tell of the day.

Where the Money Went

Not to cash. To healthcare. UnitedHealth easily topped estimates and rose 3%, Abbott jumped almost 11%, and the whole defensive shelf (staples, utilities) caught the overflow. The S&P heatmap flipped in a way it hasn't all year: the sectors that spent 2026 as dead money finished green while technology finished worst. That's rotation, not risk-off, and the difference matters enormously for what comes next.

Will AI Bounce?

The honest frame: this leg of the selloff is different from last week's. The July 8-13 flush was positioning (profit-taking, a crowded trade unwinding, Seoul contagion). Today added the first genuine fundamental challenges: a new supply threat in memory and a cost-curve problem in compute. Positioning flushes mean-revert fast. Fundamental repricings need an answer, and the answer has a date: TSMC reports Thursday. A beat-and-raise from the company that fabs the entire AI trade blunts all three of today's hammers at once. A soft guide confirms them. Everything else between now and then is noise.

The Options Angle

• Stop selling puts on the memory names until TSMC prints. The put-selling trade we've run all month worked because the flush was positioning-only. CXMT changed the distribution; the left tail is fatter now. Stand down for 24 hours, then reassess with the thesis check.
• The rotation has legs; buy it directly. XLV calls two months out, per the healthcare piece. Defensive rotations that start with earnings beats instead of fear historically run for weeks.
• If you must own the AI bounce, own it through TSMC's print, not before it. A Thursday beat is your green light; buying today is guessing on a coin flip you can watch land tomorrow.

The One-Line Read

The AI trade took its first fundamentals-based hit of the summer while healthcare produced the receipts the market's been begging for, and the index barely moved because the money rotated instead of leaving. Thursday's TSMC print is now the most important earnings report of the quarter.